Cargando…

Wechselwirkungen in der dermatologischen Systemtherapie

Severe pharmacological side effects have an occurrence of 5–7% and represent a frequent reason for hospital admission. The prevalence of undesired pharmacological side effects during hospitalization is even higher with approximately 11.5%. The causes are often interactions between drugs due to the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Krause, Kristina, Jahn, Katharina, Homey, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803714/
https://www.ncbi.nlm.nih.gov/pubmed/33242135
http://dx.doi.org/10.1007/s00105-020-04726-9
_version_ 1783636002252783616
author Krause, Kristina
Jahn, Katharina
Homey, Bernhard
author_facet Krause, Kristina
Jahn, Katharina
Homey, Bernhard
author_sort Krause, Kristina
collection PubMed
description Severe pharmacological side effects have an occurrence of 5–7% and represent a frequent reason for hospital admission. The prevalence of undesired pharmacological side effects during hospitalization is even higher with approximately 11.5%. The causes are often interactions between drugs due to the polypharmacy of multimorbid older patients. On average, a 65-year-old male patient will simultaneously be taking 5 medications. Due to the increasing use of systemic drugs in dermatology and the simultaneously increasing polypharmacy, knowledge of interactions between medications is essential for dermatologists in order to avoid severe side effects of drugs. This article provides assistance in order to identify patients and medications with a high risk for severe interactions and, therefore, to avoid the occurrence of undesired effects or the reduction of the therapeutic effects of active substances. We would like to point out that this article deals with individual aspects and does not mean that the testing of individual drug interactions with interaction programs can be omitted. It should also not be neglected that in addition to prescription-only drugs, foodstuffs, dietary supplements and herbs can also lead to interactions with medications.
format Online
Article
Text
id pubmed-7803714
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-78037142021-01-21 Wechselwirkungen in der dermatologischen Systemtherapie Krause, Kristina Jahn, Katharina Homey, Bernhard Hautarzt Übersichten Severe pharmacological side effects have an occurrence of 5–7% and represent a frequent reason for hospital admission. The prevalence of undesired pharmacological side effects during hospitalization is even higher with approximately 11.5%. The causes are often interactions between drugs due to the polypharmacy of multimorbid older patients. On average, a 65-year-old male patient will simultaneously be taking 5 medications. Due to the increasing use of systemic drugs in dermatology and the simultaneously increasing polypharmacy, knowledge of interactions between medications is essential for dermatologists in order to avoid severe side effects of drugs. This article provides assistance in order to identify patients and medications with a high risk for severe interactions and, therefore, to avoid the occurrence of undesired effects or the reduction of the therapeutic effects of active substances. We would like to point out that this article deals with individual aspects and does not mean that the testing of individual drug interactions with interaction programs can be omitted. It should also not be neglected that in addition to prescription-only drugs, foodstuffs, dietary supplements and herbs can also lead to interactions with medications. Springer Medizin 2020-11-26 2021 /pmc/articles/PMC7803714/ /pubmed/33242135 http://dx.doi.org/10.1007/s00105-020-04726-9 Text en © The Author(s) 2020 Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de.
spellingShingle Übersichten
Krause, Kristina
Jahn, Katharina
Homey, Bernhard
Wechselwirkungen in der dermatologischen Systemtherapie
title Wechselwirkungen in der dermatologischen Systemtherapie
title_full Wechselwirkungen in der dermatologischen Systemtherapie
title_fullStr Wechselwirkungen in der dermatologischen Systemtherapie
title_full_unstemmed Wechselwirkungen in der dermatologischen Systemtherapie
title_short Wechselwirkungen in der dermatologischen Systemtherapie
title_sort wechselwirkungen in der dermatologischen systemtherapie
topic Übersichten
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803714/
https://www.ncbi.nlm.nih.gov/pubmed/33242135
http://dx.doi.org/10.1007/s00105-020-04726-9
work_keys_str_mv AT krausekristina wechselwirkungeninderdermatologischensystemtherapie
AT jahnkatharina wechselwirkungeninderdermatologischensystemtherapie
AT homeybernhard wechselwirkungeninderdermatologischensystemtherapie